Bioactive secondary metabolites from the deep-sea derived fungus Aspergillus sp. SCSIO 41029

J Antibiot (Tokyo). 2021 Feb;74(2):156-159. doi: 10.1038/s41429-020-00378-y. Epub 2020 Oct 27.

Abstract

Two new compounds classified as one new lumazine peptide, penilumamide K (1) and one new sesquiterpene (2), were obtained from the deep-sea derived fungus Aspergillus sp. SCSIO 41029, together with eleven known compounds (3-13). The structures of 1-13 including absolute configurations were determined by detailed NMR spectroscopy, HR-ESI-MS, chemical derivatization, and optical rotation data. Among them, compound 1 represents the first lumazine peptide reported from deep-sea derived fungus. The bioactive assay exhibited that compounds 1, 3, 4, 5, 7 and 10 had significant potency against α-glucosidase with IC50 values ranging from 18.61 to 109.06 μΜ. In addition, compounds 4 and 9 showed strong antibacterial activity against Staphylococcus aureus with MIC values of 0.78 and 6.25 μg ml-1, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Aspergillus / chemistry
  • Aspergillus / metabolism*
  • Fermentation
  • Glucosidases / drug effects
  • Magnetic Resonance Spectroscopy
  • Methionine / analogs & derivatives
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Oligopeptides
  • Optical Rotation
  • Pteridines
  • Sesquiterpenes
  • Spectrometry, Mass, Electrospray Ionization
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents
  • Oligopeptides
  • Pteridines
  • Sesquiterpenes
  • penilumamide
  • Methionine
  • Glucosidases